Levine Mark S.
- SEC CIK
- 0001617236
No open-market purchases or sales filed in the past year.
Current role at each company
- IMVT Immunovant, Inc.Chief Legal Officeras of Nov 22, 2024
- FLXN Flexion Therapeutics IncGeneral Counselas of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Levine Mark S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMVT Immunovant, Inc.
Chief Legal Officer17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 (view filing) | Jan 26 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −10.2K | $18.51 | −$188.0K | −4.0%245.7K after | |
| Apr 26, 2023 (view filing) | Apr 25 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −2.63K | $16.29 | −$42.9K | −0.8%330.7K after | |
| Jul 27, 2023 (view filing) | Jul 26 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −3.92K | $21.63 | −$84.7K | −1.2%326.8K after | |
| Aug 25, 2023 (view filing) | Aug 24 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −12.3K | $20.30 | −$249.4K | −3.8%314.5K after | 2 lots |
| Oct 27, 2023 (view filing) | Oct 25 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −4.11K | $34.66 | −$142.3K | −1.3%310.4K after | |
| Nov 24, 2023 (view filing) | Nov 22 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −3.25K | $32.78 | −$106.6K | −1.0%307.1K after | 2 lots |
| Jan 29, 2024 (view filing) | Jan 26 | 3 days | Levine Mark S.Chief Legal Officer | SSale | −3.03K | $37.92 | −$114.8K | −1.0%304.1K after | 2 lots |
| Feb 23, 2024 (view filing) | Feb 22 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −2.13K | $36.15 | −$77.1K | −0.7%302.0K after | |
| Apr 19, 2024 (view filing) | Apr 17 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −9.83K | $29.06 | −$285.6K | −2.8%347.1K after | 2 lots |
| Apr 26, 2024 (view filing) | Apr 24 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −3.96K | $28.90 | −$114.5K | −1.1%343.2K after |
FLXN Flexion Therapeutics Inc
General Counsel1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Levine Mark S.General Counsel | SSale | −3.94K | $6.45 | −$25.4K | −2.9%133.5K after |